1-(4-Fluorophenyl)-3-phenyl-1H-pyrazol-5-ylamine, 95.0%, 1g

DABRAFENIB MESYLATE, 95%, 100mg

N-Phenyl-phthalamic acid, 95.0%, 2.5g

2-Ethoxy-n-methylbenzamide, 95%, 10g

XPhos Pd G3, ?98.0%, 10g

(S)-2,2-dimethyl-1,3-dioxolane-4-carboxylic acid, 97%, 1g

tert-Butyl (6-oxopiperidin-3-yl)carbamate, 95.0%, 10g

5-Bromo-2-chloroisopropylbenzene, 5g

Roxatidine Acetate Hydrochloride>98.0%(HPLC)(T)200mg

4-Ethynylphenol, 0.1M DEF, 5mg

3,3'-(5'-(3-(Pyridin-3-yl)phenyl)-[1,1':3',1''-terphenyl]-3,3''-diyl)dipyridine, 97%, 100mg

C -(1,3-Diphenyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 250mg

2-(2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-METHYLPROPANAMIDO)-2-METHYLPROPANOIC ACID, 95%, 5g